C
Carmen Cantisani
Researcher at Sapienza University of Rome
Publications - 104
Citations - 1190
Carmen Cantisani is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Skin cancer. The author has an hindex of 14, co-authored 85 publications receiving 850 citations. Previous affiliations of Carmen Cantisani include Policlinico Umberto I.
Papers
More filters
Journal ArticleDOI
Minoxidil use in dermatology, side effects and recent patents.
TL;DR: The mechanism of action of Minoxidil, a vasodilator medication known for its ability to slow or stop hair loss and promote hair regrowth, and use in dermatology and some patents related to alternative treatment of allergic reactions due to its use are described.
Journal ArticleDOI
Non Melanoma Skin Cancer Pathogenesis Overview
TL;DR: A review of the more recent literature about the pathogenesis of non-melanoma skin cancer focusing on basal cell carcinomas, squamous cell carcinoma and actinic keratosis focused on molecular and genetic factors and analyzed in detail several factors involved in the process.
Journal ArticleDOI
Histology of Non-Melanoma Skin Cancers: An Update
Giovanni Paolino,Giovanni Paolino,Michele Donati,Dario Didona,Santo Raffaele Mercuri,Carmen Cantisani +5 more
TL;DR: The main pathological features of different non-melanoma skin cancers are reported, serving as the gold standard during daily clinical practice in order to improve the therapeutical approaches to patients with NMSC and to understand the distinct histopathological features of N MSC.
Journal ArticleDOI
Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
Alfredo De Rossi,Carmen Cantisani,Marco Scarnò,Alessia Trucchia,Maria Caterina Fortuna,Stefano Calvieri +5 more
TL;DR: Its efficacy was not reduced as time goes on; in fact, a big proportion of subjects unchanged after 1 year, improved later on, maintaining a positive trend.
Journal ArticleDOI
Imiquimod 5% Cream Use in Dermatology, Side Effects and Recent Patents
Carmen Cantisani,Tamara Lazic,Antonio Giovanni Richetta,Rita Clerico,Carlo Mattozzi,Stefano Calvieri +5 more
TL;DR: Imiquimod use in dermatology is reviewed including its off-label use, side effects, future developments, new molecules related to dermatology and relevant patents.